1. CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer
    Ke-Da Yang et al, 2022, Molecular and Cellular Biochemistry CrossRef
  2. Chitosan-based nanoscale delivery systems in hepatocellular carcinoma: Versatile bio-platform with theranostic application
    Kimia Karimi et al, 2023, International Journal of Biological Macromolecules CrossRef
  3. MicroRNAs in the cancer cell-to-cell communication: An insight into biological vehicles
    Behnaz Mansoori et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  4. Chitosan-based smart stimuli-responsive nanoparticles for gene delivery and gene therapy: Recent progresses on cancer therapy
    Seyed Morteza Naghib et al, 2024, International Journal of Biological Macromolecules CrossRef
  5. Midkine promotes thyroid cancer cell migration and invasion by activating the phosphatidylinositol 3 kinase/protein kinase B/mammalian target of rapamycin pathway
    Li Yuan et al, 2024, Cytojournal CrossRef
  6. The Transgene Expression of the Immature Form of the HCV Core Protein (C191) and the LncRNA MEG3 Increases Apoptosis in HepG2 Cells
    Dina Mofed et al, 2022, Current Issues in Molecular Biology CrossRef
  7. Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies
    H.H. Rashwan et al, 2024, Pathology - Research and Practice CrossRef
  8. The dual role of microRNA-9 in gastrointestinal cancers: oncomiR or tumor suppressor?
    Afsane Bahrami et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  9. LncRNA AGAP2 antisense RNA 1 stabilized by insulin-like growth factor 2 mRNA binding protein 3 promotes macrophage M2 polarization in clear cell renal cell carcinoma through regulation of the microRNA-9-5p/THBS2/PI3K-Akt pathway
    Peng Xu et al, 2023, Cancer Cell International CrossRef